We supply personalized and patient-specific plasmid DNA batches in GMP-quality – within a few weeks.
Patient-specific Plasmid Platform
Personalized vaccines is a novel therapeutic approach in current clinical development. In particular, DNA vaccines based on patient-specific tumor-antigens (neoantigens) are a promising solution to cure cancer patients. The concept of personalized DNA vaccination –with individual cancer patients awaiting their treatment – require radically new approaches with respect to manufacturing logistics and effectiveness to make the vaccine in a minimal period of time.
Biomay operates a highly efficient platform process for manufacturing of patient-specific plasmid DNA vaccines. We have meanwhile an extensive track record, with more than 100 personalized pDNA batches manufactured and released.